Godwin Mulenga Chishala, is a
Nurse Anesthetist, Certified Registered based in Newburgh, Indiana. Godwin Mulenga Chishala is licensed to practice in Indiana (license number 143811) and his current practice location is
9899 Warrick Trl Apt 937, Newburgh, Indiana. He can be reached at his office (for appointments etc.) via phone at
(918) 812-5181.
NPI number for Godwin Mulenga Chishala is 1487464301 and his current mailing address is 9899 Warrick Trl Apt 937, Newburgh, Indiana. He
does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1487464301.
Provider's Profile
Full Name | Godwin Mulenga Chishala |
---|
Gender | Male |
---|
Speciality | Nurse Anesthetist, Certified Registered |
---|
Location | 9899 Warrick Trl Apt 937, Newburgh, Indiana |
---|
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
NPI Data:
- NPI Number: 1487464301
- Provider Enumeration Date: 01/13/2025
- Last Update Date: 01/13/2025
Medical Identifiers
Medical identifiers for Godwin Mulenga Chishala such as npi, medicare ID, medicare PIN, medicaid, etc.
Identifier | Type | State | Issuer |
1487464301 | NPI | - | NPPES |
Medical Taxonomies and Licenses
Taxonomy | Type | License (State) | Status |
367500000X | Nurse Anesthetist, Certified Registered | 143811 (Indiana) | Primary |
Medicare Part D Prescriber Enrollment
Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Godwin Mulenga Chishala is
NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.
Mailing Address and Practice Location
Mailing Address | Practice Location Address |
Godwin Mulenga Chishala, 9899 Warrick Trl Apt 937, Newburgh, IN 47630-3736 Ph: () - | Godwin Mulenga Chishala, 9899 Warrick Trl Apt 937, Newburgh, IN 47630-3736 Ph: (918) 812-5181 |
Reviews and Comments